It can't sell as a 'medicine' in the US without the Phase 3 testing (or it is being registered at a higher standard) though already available in Aus, Canada and UK (I think) as OTC medicine. The big US potential customer is the US defense forces who've funded their own study. Results in July i think
It can't sell as a 'medicine' in the US without the Phase 3...
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
0.002(2.22%) |
Mkt cap ! $20.97M | |||
| Open | High | Low | Value | Volume |
| 9.1¢ | 9.4¢ | 9.1¢ | $3.245K | 35.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 91539 | 9.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.3¢ | 17900 | 1 |
View Market Depth
| Last trade - 13.12pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
9.1¢ |
Change
0.002 ( 2.15 %) |
||||
| Open | High | Low | Volume | ||
| 9.4¢ | 9.4¢ | 9.1¢ | 40000 | ||
| Last updated 15.51pm 15/05/2024 ? | |||||
| IMC (ASX) Chart |